Advanced ovarian cancer in a woman with a family history of ovarian cancer, discovered at referral for prophylactic oophorectomy. A case report
Rose, P.G.; Hunter, R.E.
Journal of Reproductive Medicine 39(11): 908-910
1994
ISSN/ISBN: 0024-7758 PMID: 7853284 Document Number: 428529
Despite an initial complete response to therapy, she died of the disease 60 months after the diagnosis. Although only a small percentage of ovarian cancer patients report a family history positive for ovarian cancer, such a history remains the most recognizable risk factor in this elusive disease. Accurate prediction of the risk of ovarian cancer in subjects with multiple affected family members and the efficacy of prophylactic oophorectomy need to be determined.
Document emailed within 1 workday
Related Documents
Morice, P.; Pautier, P.; Delaloge, S.; Camatte, S.; Spatz, A.; Chompret, A.; Lhommé, C.; Duvillard, P.; Castaigne, D. 2001: Surgical management for prophylactic oophorectomy in women with an inherited risk of ovarian cancer Tumori 87(4): S16-S17Stratton, J.F.; Buckley, C.H.; Lowe, D.; Ponder, B.A. 1999: Comparison of prophylactic oophorectomy specimens from carriers and noncarriers of a BRCA1 or BRCA2 gene mutation. United Kingdom Coordinating Committee on Cancer Research (UKCCCR) Familial Ovarian Cancer Study Group Journal of the National Cancer Institute 91(7): 626-628
Menczer, J.; Dan, U.; Oelsner, G. 1994: Laparoscopic prophylactic oophorectomy in women belonging to ovarian cancer-prone families. Advantages and shortcomings European Journal of Gynaecological Oncology 15(2): 105-107
An, H.; Manaka, D.; Ikeda, Y.; Ota, T.; Nishikawa, Y.; Kudo, R.; Kawaguchi, K.; Sasaki, N.; Konishi, S.; Hamasu, S.; Nishitai, R. 2019: Rupture of Ovarian Metastasis from Cecal Cancer during Chemotherapy - A Case Report Suggestive of Bilateral Salpingo-Oophorectomy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 46(5): 941-943
Ichigo, S.; Takagi, H.; Matsunami, K.; Murase, T.; Ikeda, T.; Imai, A. 2015: A large ovarian leiomyoma discovered incidentally in a 76-year-old woman: case report European Journal of Gynaecological Oncology 36(2): 203-205
Walker, G.R.; Schlesselman, J.J.; Ness, R.B. 2002: Family history of cancer, oral contraceptive use, and ovarian cancer risk American Journal of Obstetrics and Gynecology 186(1): 8-14
Fukuyama, A.; Yokoyama, Y.; Wada, J.; Hashimoto, T.; Oda, T.; Sato, S.; Mizunuma, H. 2009: Two cases of ovarian cancer at an early stage incidentally detected using transvaginal ultrasonography in screening: importance of interval for ovarian cancer screening and selection of population with a high risk of ovarian cancer European Journal of Gynaecological Oncology 30(2): 208-210
Maruyama, M.; Noda, T.; Kiyozuka, Y.; Okamura, Y.; Ibaraki, T.; Katou, Y.; Ninomiya, Y.; Oku, M.; Nabuchi, K.; Hino, K. 1987: A case report of an advanced ovarian cancer (stage T4) treated with a total amount of 1815 mg of CDDP Gan no Rinsho. Japan Journal of Cancer Clinics 33(12): 1507-1514
Du Bois, A.; Lück, H.J.; Meier, W.; Möbus, V.; Costa, S.; Richter, B.; Warm, M.; Bauknecht, T.; Schröder, W.; Olbricht, S.; Nitz, U.; Jackisch, C. 1997: Carboplatin/paclitaxel versus cisplatin/paclitaxel as first-line chemotherapy in advanced ovarian cancer: an interim analysis of a randomized phase IIi trial of the Arbeitsgemeinschaft Gynäkologische Onkologie Ovarian Cancer Study Group Seminars in Oncology 24(5 Suppl 15: S15
Hartge, P.; Hayes, R.; Reding, D.; Sherman, M.E.; Prorok, P.; Schiffman, M.; Buys, S. 2000: Complex ovarian cysts in postmenopausal women are not associated with ovarian cancer risk factors: preliminary data from the prostate, lung, colon, and ovarian cancer screening trial American Journal of Obstetrics and Gynecology 183(5): 1232-1237
Friedenson, B.; Friedenson, H. 2002: Genetic testing for breast and ovarian cancer for women with a family history of breast cancer: weighing conflicting evidence about oral contraceptives Medgenmed: Medscape General Medicine 4(3): 3
Chen, M.Y.; Ng, K.K.; Ma, S.Y.; Wu, T.I.; Chang, T.C.; Lai, C.H. 2005: False-positive fluorine-18 fluorodeoxy-D-glucose positron emission tomography imaging caused by retained gauze in a woman with recurrent ovarian cancer: a case report European Journal of Gynaecological Oncology 26(4): 451-453
Suwannarurk, K.; Thaweekul, Y.; Mairaing, K.; Poomtavorn, Y.; Tangtiang, K.; Piyawang, W.; Bhamarapravatana, K. 2015: Bevacizumab, Carboplatin and Paclitaxel Combination Treatment in Advanced Stage Ovarian Cancer: The First Experience in Thammasat University Hospital, Thailand: A Case Report Journal of the Medical Association of Thailand 98 Suppl. 3: S121-S125
Cramer, D.W.; Hutchison, G.B.; Welch, W.R.; Scully, R.E.; Ryan, K.J. 1983: Determinants of ovarian cancer risk. I. Reproductive experiences and family history Journal of the National Cancer Institute 71(4): 711-716
Cramer, D.W.; Hutchison, G.B.; Welch, W.R.; Scully, R.E.; Ryan, K.J. 1983: Determinants of ovarian cancer risk. I. Reproductive experiences and family history Journal of the National Cancer Institute 71(4): 711-716
Kariwiga, G.; Amoa, A.B.; Mola, G.; Heywood, S. 1997: Familial ovarian cancer: report of ovarian carcinoma in three sisters Papua and new Guinea Medical Journal 40(3-4): 146-149
Kariwiga, G.; Amoa, A.B.; Mola, G.; Heywood, S. 1997: Familial ovarian cancer: report of ovarian carcinoma in three sisters Papua and new Guinea Medical Journal 40(3-4): 146-149
Rybchenko, L.A.; Bychkova, A.M.; Skyban, G.V.; Klymenko, S.V. 2013: Prognosis of probability of BRCA1 and BRCA2 mutations carriage in women with compromised family history of breast and/or ovarian cancer Problemy Radiatsiinoi Medytsyny Ta Radiobiolohii 18: 253-260
Suzuki, M.; Sekiguchi, I.; Tamada, T.; Sakurabayashi, I.; Kawai, T. 1985: Clinical evaluation of a cancer antigen CA125 associated with ovarian cancer. (III) Serum CA125 levels in patients with ovarian cancer and other gynecological tumors Rinsho Byori. Japanese Journal of Clinical Pathology 33(2): 173-177
Tanaka, K. 1989: Ovarian cancer--assessment of methods for cytogenetic analysis and chromosome aberrations found in ovarian cancer Rinsho Byori. Japanese Journal of Clinical Pathology Spec no 80: 268-280